Nasdaq

FDA expedites approval of Cochlear's Remote Check solution for cochlear implants

CENTENNIAL, Colo., April 7, 2020 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval on April 2 ...
Nasdaq

Cochlear announces FDA approval and FDA clearance of first-of-its-kind Remote Care capabilities for Nucleus and Baha Systems

LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...
Pharmabiz

Cochlear receives US FDA nod for first remote programming option for cochlear implants

Cochlear Limited, the world leader in implantable hearing solutions, has received US Food and Drug Administration approval for the first remote feature to allow follow-up programming sessions for the ...
FierceBiotech

In a first, FDA allows remote tweaking of cochlear implants

The FDA has approved the remote programming of cochlear implants via a telemedicine platform, freeing patients with severe to profound hearing loss from the need to visit specialized centers to get ...